- Home
- OXBR vs PSTV Comparison
OXBR vs PSTV Comparison
Compare OXBR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXBR
- PSTV
- Stock Information
- Founded
- OXBR 2013
- PSTV 1996
- Country
- OXBR Cayman Islands
- PSTV United States
- Employees
- OXBR N/A
- PSTV N/A
- Industry
- OXBR Property-Casualty Insurers
- PSTV Medical/Dental Instruments
- Sector
- OXBR Finance
- PSTV Health Care
- Exchange
- OXBR Nasdaq
- PSTV Nasdaq
- Market Cap
- OXBR 15.1M
- PSTV 17.0M
- IPO Year
- OXBR 2014
- PSTV N/A
- Fundamental
- Price
- OXBR $2.30
- PSTV $0.42
- Analyst Decision
- OXBR Strong Buy
- PSTV Strong Buy
- Analyst Count
- OXBR 1
- PSTV 4
- Target Price
- OXBR $5.00
- PSTV $7.88
- AVG Volume (30 Days)
- OXBR 73.7K
- PSTV 5.6M
- Earning Date
- OXBR 11-12-2025
- PSTV 11-13-2025
- Dividend Yield
- OXBR N/A
- PSTV N/A
- EPS Growth
- OXBR N/A
- PSTV N/A
- EPS
- OXBR N/A
- PSTV N/A
- Revenue
- OXBR $1,983,000.00
- PSTV $5,317,000.00
- Revenue This Year
- OXBR $497.99
- PSTV $28.09
- Revenue Next Year
- OXBR $42.14
- PSTV N/A
- P/E Ratio
- OXBR N/A
- PSTV N/A
- Revenue Growth
- OXBR N/A
- PSTV N/A
- 52 Week Low
- OXBR $1.27
- PSTV $0.16
- 52 Week High
- OXBR $5.81
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- OXBR 56.34
- PSTV 41.60
- Support Level
- OXBR $1.93
- PSTV $0.40
- Resistance Level
- OXBR $2.86
- PSTV $0.52
- Average True Range (ATR)
- OXBR 0.22
- PSTV 0.05
- MACD
- OXBR 0.04
- PSTV -0.01
- Stochastic Oscillator
- OXBR 39.78
- PSTV 15.65
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).